Interim Report 2011

Sunny Optical Technology (Group) Company Limited 舜宇光學科技（集團）有限公司 / Interim Report 2011 中期報告 8 Management Discussion and Analysis 管理層討論與分析 本集團在回顧期內為進一步加強其研發能 力，鞏固原有產品在行業中的技術領先地 位，主要三大事業分別對各自的產品進行了 升級研發，工藝技術水平得到進一步提高。 此外，由於新興光學應用領域的迅速發展， 本集團緊跟其市場需求，有針對性，有重點 地進行相關領域產品的研發。光學零件事業 方面，五百萬像素及八百萬像素手機鏡頭已 開始大量生產；多款新型車載鏡頭開始量 產；多款車載紅外鏡頭與安防紅外鏡頭已研 發完畢；多款微型投影光機與整機開發完 畢；一出多穴玻璃非球面鏡片實現量產；塑 膠注塑窄流道技術已全方位開始應用；自動 化鏡頭生產與檢驗工藝得到進一步發展及應 用。在光電產品事業方面，一千二百萬像素 手機照相模組已開發完畢；安防產品進入研 發改進階段，市場運作模式初步形成。光學 儀器事業完成對多種高階顯微、分析及測量 儀器的升級研發，並實現對環保、食品安全 領域的典型銷售，為進一步拓展光學儀器市 場打好基礎。目前，本集團擁有 131 項已獲授 專利及 45 項待批核的專利。 回顧期內，本公司股票被納入摩根士丹利資 本國際全球小型指數之中國指數成份股。晉 身摩根士丹利資本國際全球小型指數，將有 助投資者評估本集團未來的發展潛力。 During the period under review, our three major business segments have upgraded their respective existing products in R&D and further improved their processing technology standards with a view to further strengthening their R&D capabilities and consolidating their technical leadership in the respective industries. In addition, given the rapid expansion of the emerging optical application fields, the Group kept pace with the market needs by conducting R&D on the relevant products with focus. For optical components business segment, the production for 5-mega and 8-mega pixel handset lens sets has commenced; the mass production for various new vehicle lens sets has commenced; the R&D on various infrared lens sets for vehicles and security surveillance has been completed; the development for several types of micro-projectors and engines has been accomplished; the mass production for glass aspheric lenses with several cavities per mold has commenced; the application of plastic injection molding technology with narrow runway was already in full swing; automatic production and inspection technology for lens sets was further developed and applied. In respect of the optoelectronic products business segment, the development of 12-mega pixel handset camera modules have been accomplished; security surveillance products have entered the R&D upgrading process and the market operation model of which was preliminarily established. In respect of the optical instruments business segment, R&D upgrade for a number of high-end microscopes, analytical and measuring instruments has been accomplished. In addition, typical sales have been made in areas concerning environmental protection and food safety, which laid a solid foundation for further expansion of optical instrument market. Currently, the Group owns 131 issued patents and 45 patents are pending for approval. During the period under review, the Company has been added to Morgan Stanley Capital International (“MSCI”) Global Small Cap Indices – China Index. Inclusion into the MSCI Global Small Cap Index will help investors to better assess the Group’s future potential.